197 related articles for article (PubMed ID: 35479595)
1. Culture-based antibiotic susceptibility testing for
Francesco V; Zullo A; Manta R; Satriano A; Fiorini G; Pavoni M; Saracino IM; Giostra F; Monti G; Vaira D
Ann Gastroenterol; 2022; 35(2):127-134. PubMed ID: 35479595
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Resistance and Therapy Outcome in
Saracino IM; Pavoni M; Zullo A; Fiorini G; Saccomanno L; Lazzarotto T; Cavallo R; Antonelli G; Vaira D
Antibiotics (Basel); 2020 Mar; 9(3):. PubMed ID: 32183165
[TBL] [Abstract][Full Text] [Related]
3. Application of Visual Gene Clip-Based Tailored Therapy for the Eradication of
Yang L; Zou A; Wu H; Guo H; Zhang F; Zou B; Wang J
Biomed Res Int; 2021; 2021():6150628. PubMed ID: 33937401
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study.
Kwon YH; Kim N; Lee JY; Choi YJ; Yoon K; Nam RH; Suh JH; Lee JW; Lee DH
Scand J Gastroenterol; 2016 Mar; 51(3):270-6. PubMed ID: 26452405
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive molecular analysis of
Ierardi E; Giorgio F; Iannone A; Losurdo G; Principi M; Barone M; Pisani A; Di Leo A
World J Gastroenterol; 2017 Apr; 23(14):2453-2458. PubMed ID: 28465629
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility testing alone will not reliably achieve high Helicobacter pylori cure rates: A systematic review and meta-analysis.
Huang Y; Chen J; Ding Z; Liang X; Lu H
J Gastroenterol Hepatol; 2022 Jul; 37(7):1212-1221. PubMed ID: 35434851
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.
Butenko T; Jeverica S; Orel R; Homan M
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28653787
[TBL] [Abstract][Full Text] [Related]
8. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
[TBL] [Abstract][Full Text] [Related]
9. High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland.
Ferenc S; Gnus J; Kościelna M; Kinda M; Yarka A; Stewart L; Witkiewicz W
Helicobacter; 2017 Apr; 22(2):. PubMed ID: 27879042
[TBL] [Abstract][Full Text] [Related]
10. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
11. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture.
Vécsei A; Innerhofer A; Graf U; Binder C; Giczi H; Hammer K; Bruckdorfer A; Hirschl AM; Makristathis A
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):65-70. PubMed ID: 21694538
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-resistant Helicobacter pylori strains in Portuguese children.
Lopes AI; Oleastro M; Palha A; Fernandes A; Monteiro L
Pediatr Infect Dis J; 2005 May; 24(5):404-9. PubMed ID: 15876938
[TBL] [Abstract][Full Text] [Related]
14. Eradication of
Fakheri H; Saberi Firoozi M; Bari Z
Middle East J Dig Dis; 2018 Jan; 10(1):5-17. PubMed ID: 29682242
[No Abstract] [Full Text] [Related]
15. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
[TBL] [Abstract][Full Text] [Related]
16. The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradication.
Tai WC; Lee CH; Chiou SS; Kuo CM; Kuo CH; Liang CM; Lu LS; Chiu CH; Wu KL; Chiu YC; Hu TH; Chuah SK
PLoS One; 2014; 9(8):e105822. PubMed ID: 25141137
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single-center prospective pilot study.
Kwon YH; Jeon SW; Nam SY; Lee HS; Park JH
Helicobacter; 2019 Aug; 24(4):e12585. PubMed ID: 30969459
[TBL] [Abstract][Full Text] [Related]
18. Tailored eradication strategy
Choi YI; Chung JW; Kim KO; Kwon KA; Kim YJ; Kim JH; Seo JY; Park DK
World J Gastroenterol; 2021 Aug; 27(31):5247-5258. PubMed ID: 34497448
[TBL] [Abstract][Full Text] [Related]
19. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
20. Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
Zhou L; Zhang J; Song Z; He L; Li Y; Qian J; Bai P; Xue Y; Wang Y; Lin S
Helicobacter; 2016 Apr; 21(2):91-9. PubMed ID: 26104022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
